Disease/Infection News

RSS

Study finds significant decline of MRSA infections in VA long-term care facilities

Four years after implementing a national initiative to reduce methicillin-resistant Staphylococcus aureus rates in Veterans Affairs long-term care facilities, MRSA infections have declined significantly, according to a study in the January issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.

7 Jan 2014

Population Council gets USAID cooperative agreement to develop non-ARV microbicides that block HIV, STI

The Population Council today announced it was awarded a cooperative agreement from the US Agency for International Development's (USAID) Office of HIV and AIDS: "Non-ARV Based Combination Microbicide that Blocks HIV and Other STIs."

6 Jan 2014

The fight against HIV/AIDS: an interview with Dr. Mit Philips, HIV/AIDS Policy Analyst, Médecins Sans Frontières (MSF)

People mainly speak about the progress in HIV/AIDS. We at MSF know and are very conscious of the fact that there has been enormous progress, but the progress is very uneven.

6 Jan 2014

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Astellas Pharma Inc. (Astellas) and ClearPath Development Company (ClearPath) announced today a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious diseases.

6 Jan 2014

Researchers observe mating for the first time in microbes responsible for African sleeping sickness

Caught in the act! Researchers from the University of Bristol have observed mating for the first time in the microbes responsible for African sleeping sickness. This tropical disease is caused by trypanosomes, single-celled parasites that are found in the blood of those afflicted.

5 Jan 2014

EcoHealth Alliance joins Bat Conservation International to conserve bats, safeguard human health

EcoHealth Alliance, a nonprofit organization that focuses on local conservation and global health issues, and Bat Conservation International, which works to conserve bats and their habitats around the world, are joining forces in formal partnership.

3 Jan 2014

Discovery opens new pathways for treatment of toxoplasmosis and malaria

A newly identified protein and other proteins it interacts with could become effective targets for new drugs to control the parasite that cause toxoplasmosis, researchers led by investigators at Indiana University School of Medicine have reported.

3 Jan 2014

Numotion partners with The ALS Association to support individuals affected by Lou Gehrig's Disease

Numotion, the complex wheelchair company committed to serving the lifelong needs of people through individualized health and mobility solutions, has partnered with The ALS Association to offer support and enhance the quality of life for individuals affected by amyotrophic lateral sclerosis (ALS).

3 Jan 2014

Molecule produced by brain acts as natural defence mechanism against cannabis

Two INSERM research teams led by Pier Vincenzo Piazza and Giovanni Marsicano (INSERM Unit 862 "Neurocentre Magendie" in Bordeaux) recently discovered that pregnenolone, a molecule produced by the brain, acts as a natural defence mechanism against the harmful effects of cannabis in animals.

3 Jan 2014

Shingles may increase risk of stroke in later life, study finds

Having shingles may increase the risk of having a stroke years later, according to research published in the January 2, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

2 Jan 2014

Researchers reveal mechanism behind persistent bacteria

The mechanism by which some bacteria are able to survive antibacterial treatment has been revealed for the first time by Hebrew University of Jerusalem researchers. Their work could pave the way for new ways to control such bacteria.

31 Dec 2013

FDA, USDA approve SALMONELEX as GRAS food processing aid against Salmonella

FDA & USDA announced today they have approved SALMONELEX as a "GRAS" (Generally Recognized as Safe) food processing aid against Salmonella. The new product consists of natural phages against Salmonella and is produced by Micreos of The Netherlands. The company confirms that industrial scale projects with US poultry processors will start in January 2014.

31 Dec 2013

FDA accepts Cubist Pharmaceuticals' tedizolid phosphate NDA with Priority Review

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has accepted the Company's New Drug Application for its investigational antibiotic tedizolid phosphate (TR-701) with Priority Review. The FDA has assigned a Prescription Drug User Fee Act action date of June 20, 2014. Cubist is seeking FDA approval of tedizolid for the treatment of acute bacterial skin and skin structure infections.

30 Dec 2013

BioCryst receives $2.5M to advance development of BCX4430 for Marburg virus disease treatment

BioCryst Pharmaceuticals, Inc. today announced that the National Institute of Allergy and Infectious Diseases has exercised an option to conduct the investigational new drug enabling program and to submit an IND.

30 Dec 2013

Researchers provide new insights into how common cold virus infects

On average, each of us catches a cold two to three times a year. However, how the common cold virus actually infects us is only partly understood. Researchers from the Max F. Perutz Laboratories of the Medical University of Vienna and the University of Vienna, in collaboration with two Spanish groups, have now provided new insights into this process.

30 Dec 2013

CF101 drug fails to meet primary efficacy endpoint in phase III study for Dry Eye Syndrome

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.

30 Dec 2013

Research could pave way for more effective treatments for bacterial infections

30 Dec 2013

CotH protein mediates fungal invasion of host cells during mucormycosis

Opportunistic infection of individuals on immunosuppressive therapy are a major problem for patient outcome, despite current prophylactic strategies.

27 Dec 2013

Streptococcus biofilms persist on objects, surfaces in daycare center for longer periods after cleaning

Numerous scientific studies have concluded that two common bacteria that cause colds, ear infections, strep throat and more serious infections cannot live for long outside the human body.

27 Dec 2013

Researchers develop a class of compounds that may help eradicate Chagas disease

A team of researchers from Canada has developed a class of compounds which may help eradicate a neglected tropical disease that is currently hard to kill in its chronic form. The research was published ahead of print in Antimicrobial Agents and Chemotherapy.

27 Dec 2013

Disease/Infection News

Study finds significant decline of MRSA infections in VA long-term care facilities

Population Council gets USAID cooperative agreement to develop non-ARV microbicides that block HIV, STI

The fight against HIV/AIDS: an interview with Dr. Mit Philips, HIV/AIDS Policy Analyst, Médecins Sans Frontières (MSF)

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Researchers observe mating for the first time in microbes responsible for African sleeping sickness

EcoHealth Alliance joins Bat Conservation International to conserve bats, safeguard human health

Discovery opens new pathways for treatment of toxoplasmosis and malaria

Numotion partners with The ALS Association to support individuals affected by Lou Gehrig's Disease

Molecule produced by brain acts as natural defence mechanism against cannabis

Shingles may increase risk of stroke in later life, study finds

Researchers reveal mechanism behind persistent bacteria

FDA, USDA approve SALMONELEX as GRAS food processing aid against Salmonella

FDA accepts Cubist Pharmaceuticals' tedizolid phosphate NDA with Priority Review

BioCryst receives $2.5M to advance development of BCX4430 for Marburg virus disease treatment

Researchers provide new insights into how common cold virus infects

CF101 drug fails to meet primary efficacy endpoint in phase III study for Dry Eye Syndrome

Research could pave way for more effective treatments for bacterial infections

CotH protein mediates fungal invasion of host cells during mucormycosis

Streptococcus biofilms persist on objects, surfaces in daycare center for longer periods after cleaning

Researchers develop a class of compounds that may help eradicate Chagas disease

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News